Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study

BackgroundTreated or untreated non-classic congenital adrenal hyperplasia (NCCAH) diagnosed in childhood could pose an increased risk of obesity and metabolic derangements in adolescence and early adulthood. We aimed to explore the interaction between muscle-to-fat ratio (MFR) and components of meta...

Full description

Bibliographic Details
Main Authors: Asaf Ben Simon, Avivit Brener, Anat Segev-Becker, Michal Yackobovitch-Gavan, Adi Uretzky, Anita Schachter Davidov, Angelika Alaev, Asaf Oren, Ori Eyal, Naomi Weintrob, Yael Lebenthal
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1022752/full
_version_ 1811234517050982400
author Asaf Ben Simon
Avivit Brener
Avivit Brener
Anat Segev-Becker
Anat Segev-Becker
Michal Yackobovitch-Gavan
Adi Uretzky
Anita Schachter Davidov
Anita Schachter Davidov
Angelika Alaev
Angelika Alaev
Asaf Oren
Asaf Oren
Ori Eyal
Ori Eyal
Naomi Weintrob
Naomi Weintrob
Yael Lebenthal
Yael Lebenthal
author_facet Asaf Ben Simon
Avivit Brener
Avivit Brener
Anat Segev-Becker
Anat Segev-Becker
Michal Yackobovitch-Gavan
Adi Uretzky
Anita Schachter Davidov
Anita Schachter Davidov
Angelika Alaev
Angelika Alaev
Asaf Oren
Asaf Oren
Ori Eyal
Ori Eyal
Naomi Weintrob
Naomi Weintrob
Yael Lebenthal
Yael Lebenthal
author_sort Asaf Ben Simon
collection DOAJ
description BackgroundTreated or untreated non-classic congenital adrenal hyperplasia (NCCAH) diagnosed in childhood could pose an increased risk of obesity and metabolic derangements in adolescence and early adulthood. We aimed to explore the interaction between muscle-to-fat ratio (MFR) and components of metabolic syndrome in pediatric subjects with NCCAH.MethodsThis retrospective observational study was conducted in the Tel Aviv Medical Center from January 2018 to January 2022. The study group comprised 75 subjects (26 males) with NCCAH (61 hydrocortisone-treated [21 males] and 14 untreated [5 males]) and 134 healthy sex- and age-matched subjects (41 males) with normal puberty served as controls. Body composition was measured by bioelectrical impedance analysis (BIA) and muscle-to-fat ratio (MFR) z-scores were calculated. Stepwise linear regression models were applied to evaluate explanatory variables for MFR z-scores, blood pressure percentiles, lipid profiles, and glucose metabolism.ResultsThe median age [interquartile range] was 7.5 years [5.3, 8.8] at NCCAH diagnosis and 12.3 years [8.9, 15.4] at BIA. The median cumulative hydrocortisone dose was 7620 mg/m2 [2547, 12903]. Subjects with NCCAH had higher mean BMI z-scores and lower median MFR z-scores compared to controls [(0.47 ± 0.97 vs. -0.19 ± 1.04, p<0.001) and (-0.74 [-1.06, -0.14] vs.-0.37 [-0.99, 0.15], p=0.045), respectively]. The linear regression models dependent variables and their explanatory variables were: MFR z-score (R2= 0.253, p<0.001) - socioeconomic position index (β=0.348, p=0.003), birthweight z-score (β=-0.258, p=0.013), and duration of hydrocortisone treatment in years (β=0.048, p=0.023); systolic blood pressure percentile (R2 = 0.166, p<0.001) - MFR z-score (β=-9.75, p<0.001); TG/HDL ratio (R2 = 0.116, p=0.024) - MFR z-score (β=-0.300, p=0.024). No significant variables were found for glucose.ConclusionsChildren and adolescents with NCCAH have a body composition characterized by an imbalance between muscle and fat tissues, which may place them at increased risk for early-onset cardiometabolic derangements. It is reassuring that glucocorticoid therapy aimed to alleviate androgen overproduction does not appear to adversely affect their body composition.
first_indexed 2024-04-12T11:38:38Z
format Article
id doaj.art-6f5a22bb8fde4038b94a1bb9a2624add
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-12T11:38:38Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-6f5a22bb8fde4038b94a1bb9a2624add2022-12-22T03:34:46ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-10-011310.3389/fendo.2022.10227521022752Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational studyAsaf Ben Simon0Avivit Brener1Avivit Brener2Anat Segev-Becker3Anat Segev-Becker4Michal Yackobovitch-Gavan5Adi Uretzky6Anita Schachter Davidov7Anita Schachter Davidov8Angelika Alaev9Angelika Alaev10Asaf Oren11Asaf Oren12Ori Eyal13Ori Eyal14Naomi Weintrob15Naomi Weintrob16Yael Lebenthal17Yael Lebenthal18Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelNursing Services, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelBackgroundTreated or untreated non-classic congenital adrenal hyperplasia (NCCAH) diagnosed in childhood could pose an increased risk of obesity and metabolic derangements in adolescence and early adulthood. We aimed to explore the interaction between muscle-to-fat ratio (MFR) and components of metabolic syndrome in pediatric subjects with NCCAH.MethodsThis retrospective observational study was conducted in the Tel Aviv Medical Center from January 2018 to January 2022. The study group comprised 75 subjects (26 males) with NCCAH (61 hydrocortisone-treated [21 males] and 14 untreated [5 males]) and 134 healthy sex- and age-matched subjects (41 males) with normal puberty served as controls. Body composition was measured by bioelectrical impedance analysis (BIA) and muscle-to-fat ratio (MFR) z-scores were calculated. Stepwise linear regression models were applied to evaluate explanatory variables for MFR z-scores, blood pressure percentiles, lipid profiles, and glucose metabolism.ResultsThe median age [interquartile range] was 7.5 years [5.3, 8.8] at NCCAH diagnosis and 12.3 years [8.9, 15.4] at BIA. The median cumulative hydrocortisone dose was 7620 mg/m2 [2547, 12903]. Subjects with NCCAH had higher mean BMI z-scores and lower median MFR z-scores compared to controls [(0.47 ± 0.97 vs. -0.19 ± 1.04, p<0.001) and (-0.74 [-1.06, -0.14] vs.-0.37 [-0.99, 0.15], p=0.045), respectively]. The linear regression models dependent variables and their explanatory variables were: MFR z-score (R2= 0.253, p<0.001) - socioeconomic position index (β=0.348, p=0.003), birthweight z-score (β=-0.258, p=0.013), and duration of hydrocortisone treatment in years (β=0.048, p=0.023); systolic blood pressure percentile (R2 = 0.166, p<0.001) - MFR z-score (β=-9.75, p<0.001); TG/HDL ratio (R2 = 0.116, p=0.024) - MFR z-score (β=-0.300, p=0.024). No significant variables were found for glucose.ConclusionsChildren and adolescents with NCCAH have a body composition characterized by an imbalance between muscle and fat tissues, which may place them at increased risk for early-onset cardiometabolic derangements. It is reassuring that glucocorticoid therapy aimed to alleviate androgen overproduction does not appear to adversely affect their body composition.https://www.frontiersin.org/articles/10.3389/fendo.2022.1022752/fullbioelectrical impedance analysis (BIA)body compositionchildren and adolescentsfat percentagemetabolic syndrome (MetS) componentsmuscle-to-fat ratio (MFR)
spellingShingle Asaf Ben Simon
Avivit Brener
Avivit Brener
Anat Segev-Becker
Anat Segev-Becker
Michal Yackobovitch-Gavan
Adi Uretzky
Anita Schachter Davidov
Anita Schachter Davidov
Angelika Alaev
Angelika Alaev
Asaf Oren
Asaf Oren
Ori Eyal
Ori Eyal
Naomi Weintrob
Naomi Weintrob
Yael Lebenthal
Yael Lebenthal
Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
Frontiers in Endocrinology
bioelectrical impedance analysis (BIA)
body composition
children and adolescents
fat percentage
metabolic syndrome (MetS) components
muscle-to-fat ratio (MFR)
title Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
title_full Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
title_fullStr Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
title_full_unstemmed Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
title_short Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome: An observational study
title_sort body composition in children and adolescents with non classic congenital adrenal hyperplasia and the risk for components of metabolic syndrome an observational study
topic bioelectrical impedance analysis (BIA)
body composition
children and adolescents
fat percentage
metabolic syndrome (MetS) components
muscle-to-fat ratio (MFR)
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1022752/full
work_keys_str_mv AT asafbensimon bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT avivitbrener bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT avivitbrener bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT anatsegevbecker bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT anatsegevbecker bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT michalyackobovitchgavan bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT adiuretzky bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT anitaschachterdavidov bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT anitaschachterdavidov bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT angelikaalaev bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT angelikaalaev bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT asaforen bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT asaforen bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT orieyal bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT orieyal bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT naomiweintrob bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT naomiweintrob bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT yaellebenthal bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy
AT yaellebenthal bodycompositioninchildrenandadolescentswithnonclassiccongenitaladrenalhyperplasiaandtheriskforcomponentsofmetabolicsyndromeanobservationalstudy